Holen Sie sich die Stockscreener-App
9.1994
3.36%
0.2994
Handel nachbörslich:
9.06
-0.1394
-1.52%
Schlusskurs vom Vortag:
$8.90
Offen:
$8.95
24-Stunden-Volumen:
38,826
Relative Volume:
0.86
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.56%
1M Leistung:
+3.95%
6M Leistung:
-5.02%
1J Leistung:
-18.15%
1-Tages-Spanne:
$8.95
$9.25
1-Wochen-Bereich:
$8.62
$9.25
52-Wochen-Spanne:
$6.80
$11.68
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GNOM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
9.1994 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
317.66 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.89 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.11 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
249.95 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Global X Fds Genomics & Biotechnology Etf To Carry Out 1-for-4 Reverse Stock Split On September 2nd, 2025 - 富途牛牛
The Next Big Theme: July 2025 - Seeking Alpha
Stratos Wealth Partners LTD. Buys 2,865 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - 富途牛牛
Middlefield Healthcare Dividend ETF: A Strategic Play on Dividend Income and Sector Resilience - AInvest
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $13.45 - 富途牛牛
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Position Increased by Portland Global Advisors LLC - 富途牛牛
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
The long game: ASX ETFs to target amidst an ageing population - The Motley Fool Australia
Global X Genomics & Biotechnology ETF declares semi-annual distribution of $0.0083 - MSN
3 ASX ETFs that could be good value right now - The Motley Fool Australia
Oppenheimer Asset Management Inc. Has $659,000 Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
The Next Big Theme: June 2025 - Global X ETFs
Learn to Evaluate (GNOM) using the Charts - news.stocktradersdaily.com
Gene Therapy Stocks Fall Amid More Turmoil at FDA - Barron's
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Should we bet on a biotech revival? - marketscreener.com
Douglas Dynamics, Inc. (NYSE:PLOW) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Rush Street Interactive (NYSE:RSI) Raised to Strong-Buy at Wall Street Zen - Defense World
15,215 Shares in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Acquires Shares of 10,644 Mastech Digital, Inc. (NYSE:MHH) - Defense World
Citadel Advisors LLC Acquires New Position in Global X Aging Population ETF (NASDAQ:AGNG) - Defense World
8,047 Shares in Innovator U.S. Equity 5 to 15 Buffer ETF – Quarterly (BATS:EALT) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Grows Stake in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Two Sigma Investments LP Raises Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Bank of America Corp DE Cuts Stock Holdings in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
(GNOM) Trading Advice - news.stocktradersdaily.com
D. E. Shaw & Co. Inc. Purchases New Position in CureVac (NASDAQ:CVAC) - Defense World
BNP Paribas Financial Markets Buys Shares of 23,292 Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $643,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World
NETSTREIT Corp. (NYSE:NTST) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Topgolf Callaway Brands Corp. (NYSE:MODG) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 905 Shares of IMAX Co. (NYSE:IMAX) - Defense World
D. E. Shaw & Co. Inc. Purchases New Position in Inter & Co, Inc. (NASDAQ:INTR) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Position in Weis Markets, Inc. (NYSE:WMK) - Defense World
Jane Street Group LLC Invests $547,000 in GS FUT RE & INF EQY ETF (NYSEARCA:GREI) - Defense World
15,605 Shares in AllianzIM U.S. Large Cap Buffer20 Jul ETF (NYSEARCA:JULW) Purchased by Jane Street Group LLC - Defense World
BNP Paribas Financial Markets Sells 4,343 Shares of Metallus Inc. (NYSE:MTUS) - Defense World
Lulu’s Fashion Lounge (NASDAQ:LVLU) Trading Up 0.2% – Here’s Why - Defense World
D. E. Shaw & Co. Inc. Invests $109,000 in Stagwell Inc. (NASDAQ:STGW) - Defense World
D. E. Shaw & Co. Inc. Sells 5,557 Shares of Radiant Logistics, Inc. (NYSEAMERICAN:RLGT) - Defense World
D. E. Shaw & Co. Inc. Boosts Holdings in Kosmos Energy Ltd. (NYSE:KOS) - Defense World
D. E. Shaw & Co. Inc. Sells 356,504 Shares of Marqeta, Inc. (NASDAQ:MQ) - Defense World
Global X Silver Miners ETF (NYSEARCA:SIL) Shares Purchased by BNP Paribas Financial Markets - Defense World
PT Aneka Tambang Tbk (OTCMKTS:PAEKY) Trading 12.5% Higher – Here’s What Happened - Defense World
Orla Mining Ltd. (NYSEAMERICAN:ORLA) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
The Next Big Theme: May 2025 - Seeking Alpha
Hudson Pacific Properties, Inc. (NYSE:HPP) Shares Sold by Northern Trust Corp - Defense World
Jane Street Group LLC Invests $1.18 Million in Franklin Genomic Advancements ETF (BATS:HELX) - Defense World
Jane Street Group LLC Purchases 234,578 Shares of Richtech Robotics Inc. (NASDAQ:RR) - Defense World
5 Small-cap Biotech ETFs to Watch - Investing News Network
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):